Gilead Raday, Chief Operating Officer at RedHill Biopharma Ltd. (RDHL), sold 14,130,000 shares at $0.00 ($1K) on 2026-07-10, disclosed to the SEC on 2026-07-13.
Open-market sale of $1k RDHL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |